Speaker illustration

Miss Eline Feyen

University of Antwerp, Antwerp (Belgium)

Member of:

Heart Failure Association

An enthusiastic PhD student at the team of Physiopharmacology, University of Antwerp. During her research she obtained expertise in Immunocardiology, Oncology and Discovery Sciences by (high-throughput) screening and investigating a novel small-molecule treatment option related to fibrosis and heart failure.

Identification and characterization of small-molecule ERBB4 agonists as a treatment for heart failure

Event: Heart Failure 2022

Topic: Heart Failure

Session: New therapeutic approaches for heart failure


Identification of small-molecule ERBB4 agonists for the treatment of heart failure

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Heart Failure

Session: Moderated poster 10 - Heart Failure


ERBB4 and multiple microRNAs that target ERBB4 participate in pregnancy-related cardiomyopathy

Event: Heart Failure 2021

Topic: Pregnancy and Cardiovascular Disease

Session: Risk Factors and Prevention, Rehabilitation and Sports Cardiology, Cardiovascular Disease in Special Populations


Heterozygous cardiomyocyte-specific deletion of ErbB4 sensitizes to development of pregnancy-related cardiomyopathy

Event: ESC Congress 2019

Topic: Heart Failure

Session: Other cardiovascular disease


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb